Andrew Blecher, MD, is a highly trained and qualified Sports Medicine Specialist with an extensive expertise in all facets of his work, especially in the non-surgical treatment of sports injuries. He is currently serving patients at the Southern California Orthopedic Institute in Van Nuys, California, and is also affiliated with Valley Presbyterian Hospital.
Dr. Blecher attended the Tufts University School of Medicine in Boston, Massachusetts, where he gained his Doctor of Medicine Degree in 1999. He followed this with an internship and then fellowship at Kaiser Permanente Southern California, before completing an additional fellowship at the prestigious Cleveland Clinic in Ohio.
Dr. Blecher is board certified in Sports Medicine by the American Board of Family Medicine, and he is a distinguished member of the American Medical Society for Sports Medicine. He is renowned across California and beyond as an expert in sports medicine and non-surgical orthopedic treatments. Expert procedures undertaken by him include Platelet Rich Plasma Injections and the Regenexx-C cultured stem cell procedure: the world’s most advanced orthopedic stem cell treatment, Dr. Blecher is the only doctor on the Pacific coast to offer this procedure.
Learn more about Dr. Andrew Blecher here:
FindaTopDoc.com is a hub for all things medicine, featuring detailed descriptions of medical professionals across all areas of expertise, and information on thousands of healthcare topics. Each month, millions of patients use FindaTopDoc to find a doctor nearby and instantly book an appointment online or create a review. FindaTopDoc.com features each doctor’s full professional biography highlighting their achievements, experience, patient reviews and areas of expertise. A leading provider of valuable health information that helps empower patient and doctor alike, FindaTopDoc enables readers to live a happier and healthier life. For more information about FindaTopDoc, visit http://www.findatopdoc.com
This press release is distributed by PR NewsChannel. Your News. Everywhere.